Exploring M. To explore a different substance…

PiHKAL#96 M; SI#91 Mescaline
Names:
Mescaline · M · EA-1306 · Mescaline · 3,4,5-Trimethoxyphenethylamine
IUPAC name:
2-(3,4,5-Trimethoxyphenyl)ethan-1-amine
ID: 96 · Formula: C11H17NO3 · Molecular weight: 211.258
InChI: InChI=1S/C11H17NO3/c1-13-9-6-8(4-5-12)7-10(14-2)11(9)15-3/h6-7H,4-5,12H2,1-3H3

Smythies, JR. The mescaline phenomena. Br. J. Philos. Sci., 1 Feb 1953, 3 (12), 339–347. 72 kB. http://dx.doi.org/10.1093/bjps/III.12.339

Shulgin, AT. Profiles of psychedelic drugs. 7. Mescaline. J. Psychedelic Drugs, 1 Jan 1979, 11 (4), 355. 1336 kB. http://dx.doi.org/10.1080/02791072.1979.10471421

Reviriego, F; Navarro, P; Domènech, A; García-España, E. Effective complexation of psychotropic phenethylammonium salts from a disodium dipyrazolate salt of macrocyclic structure. J. Chem. Soc. Perkin Trans. 2, 2002, 1634–1638. 115 kB. http://dx.doi.org/10.1039/b200607c

Shulgin, AT; Sargent, T; Naranjo, C. Structure-activity relationships of one-ring psychotomimetics. Nature, 1 Jan 1969, 221, 537–541. 537 kB. http://dx.doi.org/10.1038/221537a0

Walters, GC; Cooper, PD. Alicyclic analogue of mescaline. Nature, 20 Apr 1968, 218 (5138), 298–300. 3141 kB. http://dx.doi.org/10.1038/218298a0

Jacob, P; Shulgin, AT. Sulfur analogues of psychotomimetic agents. 3. Ethyl homologues of mescaline and their monothioanalogues. J. Med. Chem., 1 Jan 1984, 27 (7), 881–887. 1213 kB. http://dx.doi.org/10.1021/jm00373a013

Clark, LC; Benington, F; Morin, RD. The effects of ring-methoxyl groups on biological deamination of phenethylamines. J. Med. Chem., 1 May 1965, 8 (3), 353–355. 389 kB. http://dx.doi.org/10.1021/jm00327a016

Friedhoff, AJ; Goldstein, M. New developments in metabolism of mescaline and related amines. Ann. N.Y. Acad. Sci., 1 Jan 1962, 96, 5–13. 506 kB. http://dx.doi.org/10.1111/j.1749-6632.1962.tb50097.x

Daly, J; Axelrod, J; Witkop, B. Methylation and demethylation in relation to the in vitro metabolism of mescaline. Ann. N.Y. Acad. Sci., 1 Jan 1962, 96, 37–43. 397 kB. http://dx.doi.org/10.1111/j.1749-6632.1962.tb50099.x

Lemaire, D; Jacob, P; Shulgin, AT. Ring substituted beta-methoxyphenethylamines: a new class of psychotomimetic agents active in man. J. Pharm. Pharmacol., 1 Jan 1985, 37 (8), 575–7. 1767 kB. http://dx.doi.org/10.1111/j.2042-7158.1985.tb03072.x

Moya, PR; Berg, KA; Gutiérrez-Hernandez, MA; Sáez-Briones, P; Reyes-Parada, M; Cassels, BK; Clarke, WP. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J. Pharmacol. Exp. Ther., 1 Jun 2007, 321 (3), 1054–1061. 188 kB. http://dx.doi.org/10.1124/jpet.106.117507

Ray, TS. Psychedelics and the human receptorome. PLOS ONE, 2 Feb 2010, 5 (2), e9019. 791 kB. http://dx.doi.org/10.1371/journal.pone.0009019

McGrane, O; Simmons, J; Jacobsen, E; Skinner, C. Alarming trends in a novel class of designer drugs. J. Clinic. Toxicol., 1 Nov 2011, 1 (2). 775 kB. http://dx.doi.org/10.4172/2161-0495.1000108

Shulgin, AT. Chemistry and structure-activity relationships of the psychotomimetics. In Psychotomimetic Drugs; Efron, DH, Ed., Raven Press, New York, 1 Jan 1970; pp 21–41. 8647 kB.

Fenderson5555. Two syntheses of mescaline. 21 Mar 2011. 2247 kB.

Silva, ME. Theoretical study of the interaction of agonists with the 5-HT2A receptor. Ph. D. Thesis, Universität Regensburg, Regensburg, Germany, 26 Aug 2008. 5904 kB.

Meyers-Riggs, B. Leminger’s scalines. countyourculture: rational exploration of the underground, 4 May 2012.

Ho, B; Tansey, LW; Balster, RL; An, R; McIsaac, WM; Harris, RT. Amphetamine analogs. II. Methylated phenethylamines. J. Med. Chem., 1 Jan 1970, 13 (1), 134–135. 278 kB. http://dx.doi.org/10.1021/jm00295a034

Ho, B; McIsaac, WM; An, R; Tansey, LW; Walker, KE; Englert, LF; Noel, MB. Analogs of α-methylphenethylamine (amphetamine). I. Synthesis and pharmacological activity of some methoxy andor methyl analogs. J. Med. Chem., 1 Jan 1970, 13 (1), 26–30. 601 kB. http://dx.doi.org/10.1021/jm00295a007

Kier, LB; Glennon, RA. Psychotomimetic phenalkylamines as serotonin agonists: An SAR analysis. Life Sci., 8 May 1978, 22 (18), 1589–1593. 238 kB. http://dx.doi.org/10.1016/0024-3205(78)90053-X

Nichols, DE; Shulgin, AT; Dyer, DC. Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives. Life Sci., 1 Jan 1977, 21 (4), 569–576. 320 kB. http://dx.doi.org/10.1016/0024-3205(77)90099-6

Makriyannis, A; Bowerman, D; Sze, PY; Fournier, D; De Jong., AP. Structure activity correlations in the inhibition of brain synaptosomal 3H-norepinephrine uptake by phenethylamine analogs. The role of α-alkyl side chain and methoxyl ring substitutions. Eur. J. Pharmacol., 9 Jul 1982, 81 (2), 337–340. 313 kB. http://dx.doi.org/10.1016/0014-2999(82)90454-X

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1 Jan 1978; Vol. 11, pp 243–333. 2584 kB. http://dx.doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

Bailey, K; Legault, D. 13C NMR spectra and structure of mono-, di- and trimethoxyphenylethylamines and amphetamines. Org. Magn. Resonance, 1 Jun 1983, 21 (6), 391–396. 680 kB. http://dx.doi.org/10.1002/omr.1270210611

Blaazer, AR; Smid, P; Kruse, CG. Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT2A receptors. ChemMedChem, 15 Sep 2008, 3 (9), 1299–1309. 461 kB. http://dx.doi.org/10.1002/cmdc.200800133

Trachsel, D. Fluorine in psychedelic phenethylamines. Drug Test. Analysis, 13 Dec 2011. 1038 kB. http://dx.doi.org/10.1002/dta.413

Desantis, F; Nieforth, KA. Synthesis of potential mescaline antagonists. J. Pharm. Sci., 1 Jan 1976, 65 (10), 1479–1484. 704 kB. http://dx.doi.org/10.1002/jps.2600651016

White, TJ; Goodman, D; Shulgin, AT; Castagnoli, N; Lee, R; Petrakis, NL. Mutagenic activity of some centrally active aromatic amines in Salmonella typhimurium. Mutat. Res., 1 Jan 1977, 56 (2), 199–202. 256 kB. http://dx.doi.org/10.1016/0027-5107(77)90210-X

Short, JH; Dunnigan, DA; Ours, CW. Synthesis of phenethylamines from phenylacetonitriles obtained by alkylation of cyanide ion with Mannich bases from phenols and other benzylamines. Tetrahedron, 1973, 29 (14), 1931–1939. 791 kB. http://dx.doi.org/10.1016/0040-4020(73)80127-9

Glennon, RA; Liebowitz, SM; Anderson, GM. Serotonin receptor affinities of psychoactive phenalkylamine analogues. J. Med. Chem., 1 Mar 1980, 23 (3), 294–299. 844 kB. http://dx.doi.org/10.1021/jm00177a017

Glennon, RA; Kier, LB; Shulgin, AT. Molecular connectivity analysis of hallucinogenic mescaline analogs. J. Pharm. Sci., 1 Jan 1979, 68 (7), 906–907. 252 kB. http://dx.doi.org/10.1002/jps.2600680733

Marona-Lewicka, D; Nichols, DE. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. Pharmacol. Biochem. Behav., 1 Jan 2007, 87 (4), 453–461. 266 kB. http://dx.doi.org/10.1016/j.pbb.2007.06.001

Halberstadt, AL; Geyer, MA. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology, 1 Sep 2011, 61 (3) 364–381. 817 kB. http://dx.doi.org/10.1016/j.neuropharm.2011.01.017

Ogunbodede, O; McCombs, D; Trout, K; Daley, PF; Terry, M. New mescaline concentrations from 14 taxacultivars of Echinopsis spp. (Cactaceae) (“San Pedro”) and their relevance to shamanic practice. J. Ethnopharmacol., 15 Sep 2010, 131 (2), 356–362. 324 kB. http://dx.doi.org/10.1016/j.jep.2010.07.021

Parker, MA; Kurrasch, DM; Nichols, DE. The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands. Bioorg. Med. Chem., 1 Jan 2008, 16 (8), 4661–4669. 296 kB. http://dx.doi.org/10.1016/j.bmc.2008.02.033

Thakur, M; Thakur, A; Khadikar, PV. QSAR studies on psychotomimetic phenylalkylamines. Bioorg. Med. Chem., 15 Feb 2004, 12 (4), 825–831. 323 kB. http://dx.doi.org/10.1016/j.bmc.2003.10.027

Altun, A; Golcuk, K; Kumru, M; Jalbout, AF. Electron-conformation study for the structure-hallucinogenic activity relationships of phenylalkylamines. Bioorg. Med. Chem., 1 Dec 2003, 11 (24), 3861–3868. 577 kB. http://dx.doi.org/10.1016/S0968-0896(03)00437-1

Battersby, AR; Binks, R; Huxtable, R. Biosynthesis of cactus alkaloids. Tetrahedron Lett., 1 Jan 1967, 8 (6), 563–565. 134 kB. http://dx.doi.org/10.1016/S0040-4039(00)90548-3

N-Acetylmescaline
N-Acetylmescaline
METHYL-MESCALINE
METHYL-MESCALINE; N-Methyl-3,4,5-trimethoxyphenethylamine
Trichocerine
Trichocerine
N-Formylmescaline
N-Formylmescaline
Mescaloxylic acid
Mescaloxylic acid
Mescaloruvic acid
Mescaloruvic acid
Mescaline-NBOMe
Mescaline-NBOMe; 3,4,5-Trimethoxy-N-(2-methoxybenzyl)phenethylamine
N-AL-M
N-AL-M; N-[2-(3,4,5-Trimethoxyphenyl)ethyl]prop-2-en-1-amine
N-CCCI-M
N-CCCI-M; 2-Chloro-N-[2-(3,4,5-trimethoxyphenyl)ethyl]ethan-1-amine
N-cPr-M
N-cPr-M; N-[2-(3,4,5-Trimethoxyphenyl)ethyl]cyclopropanamine
N-Pr-M
N-Pr-M; N-[2-(3,4,5-Trimethoxyphenyl)ethyl]propan-1-amine
N-CPM-M
N-CPM-M; N-(Cyclopropylmethyl)-2-(3,4,5-trimethoxyphenyl)ethan-1-amine
AEM
PiHKAL#1 AEM; SI#1 AEM
TMA
PiHKAL#157 TMA; SI#117 TMA
APM
APM; α-Propylmescaline
ABM
ABM; α-Butylmescaline
AAM
AAM; α-n-Amyl-3,4,5-trimethoxyphenethylamine
AHM
AHM; α-Hexylmescaline
ASM
ASM; α-Heptylmescaline
ANM
ANM; α-Nonylmescaline
α-D
α-D; α,α-Dideutero-3,4,5-trimethoxyphenethylamine
α-HMe-M
α-HMe-M; 2-Amino-3-(3,4,5-trimethoxyphenyl)propan-1-ol
α-CMe-M
α-CMe-M; 1-Chloro-3-(3,4,5-trimethoxyphenyl)propan-2-amine
α-MM-M
α-MM-M; 2-Methyl-1-(3,4,5-trimethoxyphenyl)propan-2-amine
α-MV-M
α-MV-M; 1-(1,3-Benzodioxol-5-yl)-2-methyl-3-(3,4,5-trimethoxyphenyl)propan-2-amine
AOM
AOM; 1-(3,4,5-Trimethoxyphenyl)decan-2-amine
α-TFMM
α-TFMM; 1,1,1-Trifluoro-3-(3,4,5-trimethoxyphenyl)propan-2-amine
α-Carboxy-mescaline
α-Carboxy-mescaline
10797
3-Methyl-3-phenylbutan-2-amine
10741
3-Methyl-3-phenylbutan-2-amine
10606
1-(4-Bromophenyl)-1,1-difluoropropan-2-amine
10605
1,1-Difluoro-1-(4-fluorophenyl)propan-2-amine
10477
N-[2-(2-Chlorophenyl)ethyl]acetamide
10183
3-(2H-1,3-Benzodioxol-5-yl)-3-methylbutan-2-amine
BOM
PiHKAL#17 BOM; SI#16 BOM
β-D
PiHKAL#51 β-D
β-HOM
β-HOM; 2-Amino-1-(3,4,5-trimethoxyphenyl)ethanol
10060
4-(2-Amino-2-methylpropyl)-N,N,3-trimethylaniline
α-Ethylamphetamine
α-Ethylamphetamine
10579
1-(4-Iodophenyl)-2-methylpropan-2-amine
10568
3-[(4-Fluorophenyl)methyl]-N-methylpentan-3-amine
10567
3-[(4-Fluorophenyl)methyl]pentan-3-amine
10566
1-(4-Fluorophenyl)-N,2-dimethylpropan-2-amine
10565
1-(4-Fluorophenyl)-2-methylpropan-2-amine
α-Methyltyrosine
α-Methyltyrosine
10515
N-Ethyl-2-methyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine
10502
3-[(3-Fluorophenyl)methyl]-N-methylpentan-3-amine
10501
3-[(3-Fluorophenyl)methyl]pentan-3-amine
10500
1-(3-Fluorophenyl)-N,2-dimethylpropan-2-amine
10499
1-(3-Fluorophenyl)-2-methylpropan-2-amine
739
Ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoate
10055
4-(2-Amino-2-methylpropyl)-3-chloro-N,N-dimethylaniline
TeMPEA
TeMPEA; 2-(2,3,4,5-Tetramethoxyphenyl)ethan-1-amine
2-CM
2-CM; 2-(2-Chloro-3,4,5-trimethoxyphenyl)ethan-1-amine
2-BM
2-BM; 2-(2-Bromo-3,4,5-trimethoxyphenyl)ethan-1-amine
ME
PiHKAL#119 ME
3-TME
PiHKAL#163 3-TME
3-DESMETHYL · 3-Demethylmescaline
3-DESMETHYL; 3-Demethylmescaline
3-Cl-4,5-DMPEA
3-Cl-4,5-DMPEA; 2-(3-Chloro-4,5-dimethoxyphenyl)ethan-1-amine
3,4,5-BMM
3,4,5-BMM; 2-(3-Bromo-4,5-dimethoxyphenyl)ethan-1-amine
AL
PiHKAL#2 AL; SI#2 AL
B
PiHKAL#10 B
CPM
PiHKAL#37 CPM
4-D
PiHKAL#50 4-D
DESOXY
PiHKAL#52 DESOXY; SI#31 DESOXY
E
PiHKAL#72 E; SI#64 Escaline
IP
PiHKAL#92 IP
MAL
PiHKAL#99 MAL
P
PiHKAL#140 P; SI#104 Proscaline
PE
PiHKAL#141 PE
PROPYNYL
PiHKAL#143 PROPYNYL
TB
PiHKAL#149 TB
4-TE
PiHKAL#151 4-TE
4-TM
PiHKAL#156 4-TM
TP
PiHKAL#174 TP
BZ
BZ; 4-Benzyloxy-3,5-dimethoxyphenethylamine
A
A; 4-n-Amyloxy-3,5-dimethoxyphenethylamine
H
H; 4-n-Hexyloxy-3,5-dimethoxyphenethylamine
S
S; 4-n-Heptyloxy-3,5-dimethoxyphenethylamine
FE
FE; Fluoroescaline
DFE
DFE; 4-(2,2-Difluoroethoxy)-3,5-dimethoxyphenethylamine
TFE
TFE; 3,5-Dimethoxy-4-(2,2,2-trifluoroethoxy)phenethylamine
FP
FP; Fluoroproscaline
IB
IB; 4-Isobutoxy-3,5-dimethoxyphenethylamine
341
3,5-Dimethoxy-4-(2-methoxyethoxy)phenethylamine
3,4,5-MBM · 4-Br-3,5-DMPEA
3,4,5-MBM; 4-Bromo-3,5-dimethoxyphenethylamine
DESMETHYL
DESMETHYL; 4-(2-Aminoethyl)-2,6-dimethoxyphenol
3,5-DMPEA
3,5-DMPEA; 2-(3,5-Dimethoxyphenyl)ethan-1-amine
3C-DFM
3C-DFM; 1-[4-(Difluoromethoxy)-3,5-dimethoxyphenyl]propan-2-amine
DFIP
DFIP; Difluoroisoproscaline
TFP
TFP; Trifluoroproscaline
TFM
TFM; Trifluoromescaline
DFM
DFM; Difluoromescaline
DMPEA
PiHKAL#60 DMPEA; SI#49 DMPEA
MP
PiHKAL#137 MP
3-TM
PiHKAL#155 3-TM
3,4,5-2C-T-7
3,4,5-2C-T-7; 2-[3,4-Dimethoxy-5-(propylsulfanyl)phenyl]ethan-1-amine
LOPHOPHINE
PiHKAL#95 LOPHOPHINE; SI#73 Lophophine
MCPA · TMT
MCPA; 3,4,5-Trimethoxytranylcypromine
265
2-(3,4,5-Trimethoxyphenoxy)ethylamine
Elemicin
Elemicin
cis-Isoelemicin
cis-Isoelemicin
Isoelemicin
Isoelemicin
Mescaline succinimide
Mescaline succinimide
Mescaline malimide
Mescaline malimide
Mescaline citrimide
Mescaline citrimide
Mescaline maleimide
Mescaline maleimide
Mescaline isocitrimide lactone
Mescaline isocitrimide lactone
Peyonine
Peyonine
Peyoglunal
Peyoglunal
Jimscaline
Jimscaline
homo-Mescaline
homo-Mescaline; 3-(3,4,5-Trimethoxyphenyl)propan-1-amine
α,N-Butenyl-M
α,N-Butenyl-M; 2-(3,4,5-Trimethoxybenzyl)-1,2,3,6-tetrahydropyridine
N,N-Butenyl-M
N,N-Butenyl-M; 1-[2-(3,4,5-Trimethoxyphenyl)ethyl]-2,5-dihydro-1H-pyrrole
M-βk
M-βk; 2-Amino-1-(3,4,5-trimethoxyphenyl)ethanone
TMAT
TMAT; 5,6,7-Trimethoxy-1,2,3,4-tetrahydronaphthalen-2-amine
504
3-(3,4,5-Trimethoxyphenyl)pyrrolidine
1310
2-(3,4,5-Trimethoxybenzyl)piperidine
1311
3-(3,4,5-Trimethoxyphenyl)piperidine
1312
2-(3,4,5-Trimethoxyphenyl)morpholine
1528
1-Methyl-4-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,4-diazepane
1529
1-Methyl-4-[2-(3,4,5-trimethoxyphenyl)ethyl]piperazine
1530
1,4-Bis[2-(3,4,5-trimethoxyphenyl)ethyl]-1,4-diazepane
1531
1,4-Bis[2-(3,4,5-trimethoxyphenyl)ethyl]piperazine
3,4,5-Trimethoxybenzylamine
3,4,5-Trimethoxybenzylamine
Propargylpemoline
Propargylpemoline
10846
2-(Dimethylamino)-5-methyl-5-phenyl-1,3-oxazol-4(5H)-one
BOHD
PiHKAL#16 BOHD
IM
PiHKAL#91 IM; SI#72 IM
TMPEA
PiHKAL#168 TMPEA; SI#124 TMPEA-2
TMPEA-5 · 2C-TMA-5
TMPEA-5; 2,3,6-Trimethoxyphenethylamine
TMPEA-6 · 2C-TMA-6
TMPEA-6; 2,4,6-Trimethoxyphenethylamine
N-Me-3-DESMETHYL
N-Me-3-DESMETHYL; N-Methyl-3-demethylmescaline
2C-pEtOH
2C-pEtOH; 4-(2-Hydroxyethyl)-2,5-dimethoxyphenethylamine
DOOH
DOOH; 4-Hydroxy-2,5-dimethoxyamphetamine
β-HO-2,5-DMA
β-HO-2,5-DMA; 2,5-Dimethoxynorephedrine
β,3,4-HO-N-iPr-DHPEA
β,3,4-HO-N-iPr-DHPEA; 4-[1-Hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol
MHMAOH
MHMAOH; 4-{2-[Hydroxy(methyl)amino]propyl}-2-methoxyphenol
N,N-Me-HME
N,N-Me-HME; 5-[2-(Dimethylamino)-1-hydroxyethyl]-2-methoxyphenol
N-Me-DME
N-Me-DME; 1-(3,4-Dimethoxyphenyl)-2-(methylamino)ethan-1-ol
β,3,4-TMPEA
β,3,4-TMPEA; 2-(3,4-Dimethoxyphenyl)-2-methoxyethan-1-amine
DMAOH
DMAOH; 1-(3,4-Dimethoxyphenyl)-N-hydroxypropan-2-amine
β-HO-DMA
β-HO-DMA; 2-Amino-1-(3,4-dimethoxyphenyl)propan-1-ol
β-HO-4,3-EMPEA
β-HO-4,3-EMPEA; 2-Amino-1-(4-ethoxy-3-methoxyphenyl)ethanol
β,2-HO-N-Me-5-MA
β,2-HO-N-Me-5-MA; 2-[1-Hydroxy-2-(methylamino)propyl]-4-methoxyphenol
β-HO-N-Me-2,5-DMPEA
β-HO-N-Me-2,5-DMPEA; 1-(2,5-Dimethoxyphenyl)-2-(methylamino)ethanol
BODM
BODM; 2-(2,5-Dimethoxyphenyl)-2-methoxyethan-1-amine
β-HO,Me-2,5-DMPEA
β-HO,Me-2,5-DMPEA; 1-Amino-2-(2,5-dimethoxyphenyl)propan-2-ol
β,2-HO-N-Me-5-EPEA
β,2-HO-N-Me-5-EPEA; 4-Ethoxy-2-[1-hydroxy-2-(methylamino)ethyl]phenol
β,2-HO-5-EA
β,2-HO-5-EA; 2-(2-Amino-1-hydroxypropyl)-4-ethoxyphenol
β-HO-N-Me-3,5-DMPEA
β-HO-N-Me-3,5-DMPEA; 1-(3,5-Dimethoxyphenyl)-2-(methylamino)ethanol
β-HO-N-Me-2,6-DMPEA
β-HO-N-Me-2,6-DMPEA; 1-(2,6-Dimethoxyphenyl)-2-(methylamino)ethanol
TMPEA-4
TMPEA-4; 2-(2,3,5-Trimethoxyphenyl)ethan-1-amine
N-HO-2C-D
N-HO-2C-D; 2-(2,5-Dimethoxy-4-methylphenyl)-N-hydroxyethan-1-amine
α-Me-3-DESMETHYL
α-Me-3-DESMETHYL; 5-(2-Aminopropyl)-2,3-dimethoxyphenol
DESMETHYL-M
DESMETHYL-M; 2,6-Dimethoxy-4-[2-(methylamino)ethyl]phenol
α-Me-DESMETHYL
α-Me-DESMETHYL; 4-(2-Aminopropyl)-2,6-dimethoxyphenol
10030
3-{1-Hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol
Orciprenaline
Orciprenaline
N-Methyl-3,4,5-trimethoxybenzylamine
N-Methyl-3,4,5-trimethoxybenzylamine
Dichloroisoprenaline
Dichloroisoprenaline
Orciprenaline
Orciprenaline
10066
2-Amino-1-(2,4-dimethoxyphenyl)propan-1-ol
N-Acetylmescaline
N-Acetylmescaline
METHYL-MESCALINE
METHYL-MESCALINE; N-Methyl-3,4,5-trimethoxyphenethylamine
Trichocerine
Trichocerine
N-Formylmescaline
N-Formylmescaline
Mescaloxylic acid
Mescaloxylic acid
Mescaloruvic acid
Mescaloruvic acid
Mescaline-NBOMe
Mescaline-NBOMe; 3,4,5-Trimethoxy-N-(2-methoxybenzyl)phenethylamine
N-AL-M
N-AL-M; N-[2-(3,4,5-Trimethoxyphenyl)ethyl]prop-2-en-1-amine
N-CCCI-M
N-CCCI-M; 2-Chloro-N-[2-(3,4,5-trimethoxyphenyl)ethyl]ethan-1-amine
N-cPr-M
N-cPr-M; N-[2-(3,4,5-Trimethoxyphenyl)ethyl]cyclopropanamine
N-Pr-M
N-Pr-M; N-[2-(3,4,5-Trimethoxyphenyl)ethyl]propan-1-amine
N-CPM-M
N-CPM-M; N-(Cyclopropylmethyl)-2-(3,4,5-trimethoxyphenyl)ethan-1-amine
AEM
PiHKAL#1 AEM; SI#1 AEM
TMA
PiHKAL#157 TMA; SI#117 TMA
APM
APM; α-Propylmescaline
ABM
ABM; α-Butylmescaline
AAM
AAM; α-n-Amyl-3,4,5-trimethoxyphenethylamine
AHM
AHM; α-Hexylmescaline
ASM
ASM; α-Heptylmescaline
ANM
ANM; α-Nonylmescaline
α-D
α-D; α,α-Dideutero-3,4,5-trimethoxyphenethylamine
α-HMe-M
α-HMe-M; 2-Amino-3-(3,4,5-trimethoxyphenyl)propan-1-ol
α-CMe-M
α-CMe-M; 1-Chloro-3-(3,4,5-trimethoxyphenyl)propan-2-amine
α-MM-M